Suppliers / Danapha Pharmaceutical Joint Stock

Danapha Pharmaceutical Joint Stock

Vietnam Updated 9 July 2026

Danapha Pharmaceutical Joint Stock is a finished-dose manufacturer based in Vietnam. It appears in 14 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with UZPHARM (UZ) and RCETH (BY). Its GMP standing is certified by EMA and EAEU_EEC.

0
active US DMFs
0
valid CEPs
2
registered plants
14
filings across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Дананг, Belarus Not on file
Da Nang, Vietnam Not on file

What they file, and where

Molecule Regulators Docs
Haloperidol DAV (Vietnam) 2

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
UZPHARM (UZ) 12 None
RCETH (BY) 2 None
EMA None 1
EAEU_EEC None 1

Comparing suppliers?

Choose your molecules and target markets. Danapha Pharmaceutical Joint Stock comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates